IRCT201612069014N137
Completed
Phase 2
Effect of hormonal therapy versus no treatment on testicular histopathology and fertility in patients with non-obstructive azoospermia: a before-after clinical trial
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 sites28 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- non-obstructive azoospermia.
- Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Enrollment
- 28
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male; non\-obstructive azoospermia; normal sexual hormones.
- •Exclusion criteria: Severe testicular atrophy; varicocele; chromosomal abnormality; sertoli cell syndrome; hypogonadism.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Comparison between different doses of gonadotropin-releasing hormone agonist used in short stimulation protocol in infertile women undergoing IVFInfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12613000384752Sarhan IVF Cntre90
Active, not recruiting
Not Applicable
Effect of hormone replacement therapy versus risedronate on fracture recurrence in postmenopausal women with hip fractureEndocrine, nutritional and metabolic diseaseKCT0005513Samsung Medical Center300
Not yet recruiting
Not Applicable
The effects of gender affirming hormone therapy on skeletal muscle training and epigeneticsmuscle health and performancebody compositionmetabolic healthgender dysphoriaMusculoskeletal - Normal musculoskeletal and cartilage development and functionMetabolic and Endocrine - Other endocrine disordersACTRN12621001415897Victoria University160
Completed
Phase 3
Comparative effects of 2 types of hormone replacement therapy on climacteric symptomsmenopause.Menopausal and female climacteric statesIRCT138809032766N1Tarbiat Maodares University150
Active, not recruiting
Not Applicable
Modulation of response to hormonal therapy with lapatinib and/or metformin in patients with HER2-negative, ER and/or PgR positive metastatic breast cancer with progressive disease after first-line hormonal therapyFemale patients with HER2-negative, ER and/or PgR positive breast cancer in progression after first-line hormonal therapyMedDRA version: 14.1Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-000155-16-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI